glp-1 receptor agonist market top selling drugs us Agonists Exclusive Research Report 2025 GLP-1 Receptor Agonist Market Size
Description
A February study of more than 98,000 U.S
10.1056/NEJMoa1607141 [DOI] [PubMed] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article
Nature 546 , 259264 (2017)
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study
